Release Details

The Presentation Will Be Webcast Wednesday, March 24, 2004

SAN DIEGO, March 23 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will present at the Wells Fargo Securities Healthcare Conference at the St. Regis Hotel in New York City tomorrow, Wednesday, March 24, 2004 at 12:00PM Eastern Standard Time and 9:00AM Pacific Standard Time. The presentation will be simultaneously webcast and can be accessed on the Company's website at http://www.neurocrine.com.

The conference format will include a presentation and fireside chat. Gary Lyons, President and Chief Executive Officer of Neurocrine will respond to questions on indiplon, the Company's late stage clinical development program for the treatment of insomnia, and will highlight results from recently completed Phase III clinical trials.

If you are unable to attend the webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 658-7600 and ask for Claudia Jones or Elizabeth Foster. A replay will become available approximately one hour after the live webcast concludes. Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software. The presentation will be archived until Wednesday, March 31, 2004.

Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, certain female and male disorders, anxiety, depression, diabetes, multiple sclerosis, irritable bowel syndrome, eating disorders, pain, and autoimmunity. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the Internet at http://www.neurocrine.com

SOURCE Neurocrine Biosciences, Inc.